Wheezing clinical trials

Explore recruiting wheezing clinical trials.

Recruiting wheezing studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Wheezing trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Protecting late-moderate preterm infants from respiratory tract infections and wheeze in their first year of life by using bacterial lysates

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing - The INSTAR study

Finland, Sweden, Norway

Therapeutic use (Phase IV) EU CTIS Study details

A randomized, double-blind, placebo-controlled, parallel group study to assess the efficacy and long-term safety of dupilumab in children 2 to <6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze

Poland, Hungary, Czechia, Netherlands, Greece, Italy +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age: RhinoPOC RCT

Finland

Therapeutic use (Phase IV) EU CTIS Study details

Inhaled corticosteroids in young children with episodic wheezing: a multicenter cluster RCT

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess the Efficacy and Safety of Daily OM-85 Treatment vs. Placebo given in Children Aged 6 Months to 5 Years with Recurrent Wheezing

Hungary, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Wheezing trials by city

Wheezing in Toronto Wheezing in Vancouver Wheezing in Montreal Wheezing in Calgary Wheezing in Edmonton Wheezing in Ottawa Wheezing in Winnipeg Wheezing in Quebec City Wheezing in Hamilton Wheezing in Kitchener Wheezing in London Wheezing in Halifax Wheezing in New York Wheezing in Los Angeles Wheezing in Chicago Wheezing in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease